Faulty regulation of tau phosphorylation by the reelin signal transduction pathway is a potential mechanism of pathogenesis and therapeutic target in Alzheimer's disease

European Neuropsychopharmacology

Volumn 16, Issue 8, 2006, Pages 547-551

  Deutsch, Stephen I ^a,b   Rosse, Richard B ^a,b   Deutsch, Lynn H ^b  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Low density lipoprotein receptors; Reelin; Tau

Indexed keywords

APOLIPOPROTEIN E; INSULIN; LITHIUM ION; REELIN; SOMATOMEDIN C; TAU PROTEIN;

ALZHEIMER DISEASE; BRAIN DEVELOPMENT; BRAIN REGION; CELL MIGRATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GENE MUTATION; HUMAN; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; ANIMALS; BRAIN; CELL ADHESION MOLECULES, NEURONAL; EXTRACELLULAR MATRIX PROTEINS; HUMANS; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; PHOSPHORYLATION; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION; TAU PROTEINS;

EID: 33750813253     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2006.01.006     Document Type: Review

References (20)

1. Benhayon D., Magdaleno S., and Curran T. Binding of purified reelin to apoER2 and VLDLR mediates tyrosine phosphorylation of Disabled-1. Mol. Brain Res. 112 (2003) 33-45
2. Bhat R.V., Haeberlein S.L.B., and Avila J. Glycogen synthase kinase 3: a drug target for CNS therapies. J. Neurochem. 89 (2004) 1313-1317
3. Bock H.H., and Herz J. Reelin activates Src family tyrosine kinases in neurons. Curr. Biol. 13 (2003) 18-26
4. Cooper J.A., and Howell B.W. Lipoprotein receptors: signaling functions in the brain?. Cell 97 (1999) 671-674
5. Costa E., Chen Y., Davis J., Dong E., Noh J.S., Tremolizzo L., Veldic M., Grayson D.R., and Guidotti A. Reelin and schizophrenia: a disease at the interface of the genome and epigenome. Mol. Interv. 2 (2002) 47-57
6. Costa E., Davis J., Pesold C., Tueting P., and Guidotti A. The heterozygote reeler mouse as a model for the development of a new generation of antipsychotics. Curr. Opin. Pharmacol. 2 (2002) 56-62
7. D'Arcangelo G., Homayouni R., Keshvara L., Rice D.S., Sheldon M., and Curran T. Reelin is a ligand for lipoprotein receptors. Neuron 24 (1999) 471-479
8. 67) expression in schizophrenia and bipolar disorder. Arch. Gen. Psychiatry 57 (2000) 1061-1069
9. Hiesberger T., Trommsdorff M., Howell B.W., Goffinet A., Mumby M.C., Cooper J.A., and Herz J. Direct binding of reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24 (1999) 481-489
10. Hong M., Chen D.C.R., Klein P.S., and Lee V.M.-Y. Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J. Biol. Chem. 272 40 (1997) 25326-25332
11. Hong M., and Lee V.M.-Y. Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J. Biol. Chem. 272 31 (1997) 19547-19553
12. Liu W.S., Pesold C., Rodriguez M.A., Carboni G., Auta J., Lacor P., Larson J., Condie B.G., Guidotti A., and Costa E. Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse. Proc. Natl. Acad. Sci. U. S. A. 98 6 (2001) 3477-3482
13. Ohkubo N., Lee Y.-D., Morishima A., Terashima T., Kikkawa S., Tohyama M., Sakanaka M., Tanaka J., Maeda N., Vitek M.P., and Mitsuda N. Apolipoprotein E and reelin ligands modulate tau phosphorylation through an apolipoprotein E receptor/disabled-1/glycogen synthase kinase-3β cascade. FASEB J. 17 2 (2003) 295-297
14. Rice D.S., and Curran T. Mutant mice with scrambled brains: understanding the signaling pathways that control cell positioning in the CNS. Genes Dev. 13 (1999) 2758-2773
15. Schneider W.J., and Nimpf J. LDL receptor relatives at the crossroad of endocytosis and signaling. Cell Mol. Life Sci. 60 (2003) 892-903
16. Sun W., Qureshi H.Y., Cafferty P.W., Sobue K., Agarwal-Mawal A., Neufield K.D., and Paudel H.K. Glycogen synthase kinase-3β is complexed with tau protein in brain microtubules. J. Biol. Chem. 277 14 (2002) 11933-11940
17. Tesseur I., Van Dorpe J., Spittaels K., Van den Haute C., Moechars D., and Van Leuven F. Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice. Am. J. Pathol. 156 3 (2000) 951-964
18. Tremolizzo L., Doueiri M.-S., Dong E., Grayson D.R., Davis J., Pinna G., Tueting P., Rodriguez-Menendez V., Costa E., and Guidotti A. Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice. Biol. Psychiatry 57 (2005) 500-509
19. Trommsdorff M., Gotthardt M., Hiesberger T., Shelton J., Stockinger W., Nimpf J., Hammer R.E., Richardson J.A., and Herz J. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and apoE receptor 2. Cell 97 (1999) 689-701
20. Weeber E.J., Beffert U., Jones C., Christian J.M., Forster E., Sweatt J.D., and Herz J. Reelin and apoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J. Biol. Chem. 277 42 (2002) 39944-39952